Fenofibrate Targets Atherosclerosis Progression

Fenofibrate Targets Atherosclerosis Progression

Cardiovascular disease is the major cause of mortality worldwide and accounts for approximately 40% of all deaths. Dyslipidaemia is one of the primary causes of atherosclerosis and effective interventions to correct dyslipidaemia should form an integral component of any strategy aimed at preventing cardiovascular disease. Fibrates have played a major role in the treatment of hyperlipidaemia for more than two decades. Fenofibrate is one of the most commonly used fibrates worldwide

Modern Medicine – Issue 3 2021